Clinical Trial Update: The Effects of Nateglinide and Acarbose on the Post-Prandial Glucose Control in Type 2 Diabetic Patients [Phase 4]

View source ↗

Summary

Phase 4 trial evaluating the effects of nateglinide and acarbose on post-prandial glucose control in type 2 diabetes mellitus; the study has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetes Mellitus
• Type 2 Diabetes Mellitus

Drugs mentioned

• Precose (acarbose)
• Starlix (nateglinide)

Snippet

Sponsor: Inje University | Conditions: Diabetes Mellitus, Type 2 Diabetes Mellitus | Phase 4 | Status: COMPLETED